Allen M. Gown
#113,014
Most Influential Person Now
Allen M. Gown's AcademicInfluence.com Rankings
Allen M. Gownbiology Degrees
Biology
#6371
World Rank
#9068
Historical Rank
Histology
#3
World Rank
#10
Historical Rank
Pathology
#76
World Rank
#163
Historical Rank
Download Badge
Biology
Allen M. Gown's Degrees
- Doctorate Medicine University of Washington
- PhD Pathology University of Washington
Why Is Allen M. Gown Influential?
(Suggest an Edit or Addition)Allen M. Gown's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma (2004) (2618)
- Characterization of the Early Lesion of ‘Degenerative’ Valvular Aortic Stenosis: Histological and Immunohistochemical Studies (1994) (1267)
- Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. (1986) (676)
- CDX2, a Highly Sensitive and Specific Marker of Adenocarcinomas of Intestinal Origin: An Immunohistochemical Survey of 476 Primary and Metastatic Carcinomas (2003) (650)
- Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors (1997) (612)
- Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. (1989) (602)
- Localization of PDGF-B protein in macrophages in all phases of atherogenesis. (1990) (577)
- Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. (1986) (516)
- Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system. (1999) (497)
- An international Ki67 reproducibility study. (2013) (475)
- Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. (1991) (475)
- HER-2 testing in breast cancer using parallel tissue-based methods. (2004) (442)
- HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization. (1987) (427)
- PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model (1991) (420)
- Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. (2013) (418)
- Monoclonal antibodies to human intermediate filament proteins. II. Distribution of filament proteins in normal human tissues. (1984) (409)
- Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group. (2018) (398)
- Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. (1993) (382)
- Current issues in ER and HER2 testing by IHC in breast cancer (2008) (355)
- Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. (2009) (354)
- Improved Detection of Apoptotic Cells in Archival Paraffin Sections: Immunohistochemistry Using Antibodies to Cleaved Caspase 3 (2002) (341)
- Application of Photoshop-based Image Analysis to Quantification of Hormone Receptor Expression in Breast Cancer (1997) (334)
- Fatty streak initiation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. (1987) (331)
- Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer. (1999) (330)
- Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. (1999) (321)
- Mechanisms of arterial graft failure. 1. Role of cellular proliferation in early healing of PTFE prostheses. (1985) (317)
- Long–term hepatic adenovirus–mediated gene expression in mice following CTLA4Ig administration (1995) (306)
- Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. (1991) (302)
- Immunocytochemical analysis of cellular components in atherosclerotic lesions. Use of monoclonal antibodies with the Watanabe and fat-fed rabbit. (1986) (280)
- Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers. (2008) (278)
- Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue. (1992) (277)
- Enhanced expression of "muscle-specific" actin in glomerulonephritis. (1992) (273)
- HHF35, a muscle actin-specific monoclonal antibody. II. Reactivity in normal, reactive, and neoplastic human tissues. (1987) (267)
- Nuclear beta-catenin in mesenchymal tumors (2005) (265)
- Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. (1989) (249)
- Poorly differentiated synovial sarcoma: immunohistochemical distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors. (1998) (242)
- A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes (1985) (242)
- Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors. (1999) (236)
- Quantitative Imaging of Estrogen Receptor Expression in Breast Cancer with PET and 18F-Fluoroestradiol (2008) (232)
- Complete Chromogen Separation and Analysis in Double Immunohistochemical Stains Using Photoshop-based Image Analysis (1999) (229)
- An international study to increase concordance in Ki67 scoring (2015) (211)
- Monoclonal antibodies to human intermediate filament proteins. III. Analysis of tumors. (1985) (211)
- Distribution of SPARC in normal and neoplastic human tissue. (1995) (209)
- Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival. (2006) (200)
- Persistent hepatitis C virus infection after liver transplantation: Clinical and virological features (1995) (200)
- Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver. (1997) (187)
- Cytokeratins 7 and 20 in Primary and Secondary Mucinous Tumors of the Ovary: Analysis of Coordinate Immunohistochemical Expression Profiles and Staining Distribution in 179 Cases (2006) (183)
- P504S Immunohistochemical Detection in 405 Prostatic Specimens Including 376 18-Gauge Needle Biopsies (2002) (181)
- Hepatic veno-occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules. (1987) (180)
- Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity (2006) (179)
- Pure Epithelioid PEComas (So-Called Epithelioid Angiomyolipoma) of the Kidney: A Clinicopathologic Study of 41 Cases: Detailed Assessment of Morphology and Risk Stratification (2011) (179)
- Human atherosclerosis. III. Immunocytochemical analysis of the cell composition of lesions of young adults. (1992) (175)
- PCNA/cyclin expression and BrdU uptake define different subpopulations in different cell lines. (1991) (175)
- Intracystic Papillary Carcinomas of the Breast: A Reevaluation Using a Panel of Myoepithelial Cell Markers (2006) (174)
- Fatty streak expansion and maturation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. (1987) (173)
- Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7 (2006) (168)
- Various cell types in human atherosclerotic lesions express ICAM-1. Further immunocytochemical and immunochemical studies employing monoclonal antibody 10F3. (1992) (163)
- Immunohistochemical Distinction of Invasive From Noninvasive Breast Lesions: A Comparative Study of p63 Versus Calponin and Smooth Muscle Myosin Heavy Chain (2003) (159)
- Somatic mutations are frequent and increase with age in human kidney epithelial cells. (1996) (159)
- Optimal Immunohistochemical Markers For Distinguishing Lung Adenocarcinomas From Squamous Cell Carcinomas in Small Tumor Samples (2010) (157)
- Perlecan Protein Core Interacts with Extracellular Matrix Protein 1 (ECM1), a Glycoprotein Involved in Bone Formation and Angiogenesis* (2003) (157)
- Ovarian Mucinous Tumors Associated With Mature Cystic Teratomas: Morphologic and Immunohistochemical Analysis Identifies a Subset of Potential Teratomatous Origin That Shares Features of Lower Gastrointestinal Tract Mucinous Tumors More Commonly Encountered as Secondary Tumors in the Ovary (2007) (155)
- p63 Expression in Lung Carcinoma: A Tissue Microarray Study of 408 Cases (2004) (152)
- Diagnostic utility of galectin-3 in thyroid cancer. (2010) (149)
- Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall (2008) (146)
- Clear Cell Tumor of the Lung Immunohistochemical and Ultrastructural Evidence of Melanogenesis (1991) (143)
- BAP1 Immunohistochemistry and p16 FISH to Separate Benign From Malignant Mesothelial Proliferations (2015) (142)
- Malignant vascular tumors of the serous membranes mimicking mesothelioma. A report of 14 cases. (1996) (141)
- Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood. (1995) (141)
- NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry. (2009) (139)
- Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms. (2009) (137)
- Coexpression of intermediate filaments in human epithelial neoplasms. (1985) (137)
- Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens (2016) (133)
- Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism. (2008) (132)
- Renal angiomyolipoma: further immunophenotypic characterization of an expanding morphologic spectrum. (2001) (132)
- Nonsmall Cell Lung Carcinoma With Neuroendocrine Differentiation—An Entity of No Clinical or Prognostic Significance (2007) (131)
- The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma. (2009) (127)
- Determining true HER2 gene status in breast cancers with polysomy by using alternative chromosome 17 reference genes: implications for anti-HER2 targeted therapy. (2011) (125)
- Human epidermal growth factor receptor 2 assessment in a case-control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription polymerase chain reaction performed by central laboratories. (2010) (121)
- The immunophenotype of hemangiopericytomas and glomus tumors, with special reference to muscle protein expression: an immunohistochemical study and review of the literature. (1991) (118)
- HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry. A study of interlaboratory agreement. (2000) (117)
- Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration (2016) (116)
- Carcinoma of the Collecting Ducts of Bellini and Renal Medullary Carcinoma: Clinicopathologic Analysis of 52 Cases of Rare Aggressive Subtypes of Renal Cell Carcinoma With a Focus on Their Interrelationship (2012) (116)
- Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases (2006) (115)
- Smooth muscle cells can express cytokeratins of "simple" epithelium. Immunocytochemical and biochemical studies in vitro and in vivo. (1988) (114)
- Anomalous cytokeratin expression in malignant melanoma: one- and two-dimensional western blot analysis and immunohistochemical survey of 100 melanomas. (1990) (114)
- Expression of Platelet-derived Growth Factor B-Chain and the Platelet-derived Growth Factor Receptor β Subunit in Human Breast Tissue and Breast Carcinoma (1995) (113)
- Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma. (2000) (110)
- Human atherosclerosis. IV. Immunocytochemical analysis of cell activation and proliferation in lesions of young adults. (1993) (108)
- The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice (2020) (108)
- Rhabdoid tumors of the kidney contain mesenchymal specific and epithelial specific intermediate filament proteins. (1984) (107)
- COORDINATE EXPRESSION OF CYTOKERATIN-7 AND CYTOKERATIN-20 DEFINES UNIQUE SUBSETS OF CARCINOMAS (1995) (107)
- Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases. (1998) (105)
- Wilms Tumor Gene Product: Sensitive and Contextually Specific Marker of Serous Carcinomas of Ovarian Surface Epithelial Origin (2004) (105)
- Anti-melanoma monoclonal antibody HMB45 identifies an oncofetal glycoconjugate associated with immature melanosomes. (1992) (103)
- Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases (2008) (100)
- A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin. (2000) (99)
- High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system (2008) (98)
- Metabolism of very-low-density lipoprotein triglyceride by human placental cells: the role of lipoprotein lipase. (1992) (98)
- Immunohistochemical characterization of atypical fibroxanthoma and dermatofibrosarcoma protuberans. (1992) (97)
- Concordance study of PD-L1 expression in primary and metastatic bladder carcinomas: comparison of four commonly used antibodies and RNA expression (2017) (96)
- p16 Expression in Primary Ovarian Mucinous and Endometrioid Tumors and Metastatic Adenocarcinomas in the Ovary: Utility for Identification of Metastatic HPV-Related Endocervical Adenocarcinomas (2007) (92)
- Identification of molecular markers altered during transformation of differentiated into anaplastic thyroid carcinoma. (2007) (92)
- Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue. (1992) (90)
- Overexpression of P53 in head and neck cancer (1992) (90)
- Low-Grade (Fibromatosis-Like) Spindle Cell Carcinoma of the Breast (2001) (90)
- Immunolocalization of three novel smooth muscle-specific proteins in salivary gland pleomorphic adenoma: assessment of the morphogenetic role of myoepithelium. (1997) (90)
- Ovarian Atypical Proliferative (Borderline) Mucinous Tumors: Gastrointestinal and Seromucinous (Endocervical-Like) Types are Immunophenotypically Distinctive (2006) (90)
- HMB-45: A Review (1996) (88)
- Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis. (2001) (86)
- BAP1 Immunohistochemistry and p16 FISH in the Diagnosis of Sarcomatous and Desmoplastic Mesotheliomas (2016) (83)
- Thyroid Transcription Factor-1 Expression in Breast Carcinomas (2010) (82)
- Guidelines for Pathologic Diagnosis of Malignant Mesothelioma (2017) (82)
- Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen (2015) (82)
- C‐ERBB‐2 oncogens protein in In situ and invasive lobular breast neoplasia (1991) (82)
- Differential Expression of Myoepithelial Markers in Salivary, Sweat and Mammary Glands (2000) (79)
- Production of a monoclonal antibody to an attachment protein derived from human cementum (1992) (79)
- E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions. (2001) (78)
- A monoclonal antibody against nerve growth factor receptor. Immunohistochemical analysis of normal and neoplastic human tissue. (1989) (77)
- Salivary gland basal cell and canalicular adenomas: immunohistochemical demonstration of myoepithelial cell participation and morphogenetic considerations. (2000) (76)
- Immunohistochemical analysis of gynecologic tumors. (2001) (76)
- Probucol treatment affects the cellular composition but not anti-oxidized low density lipoprotein immunoreactivity of plaques from Watanabe heritable hyperlipidemic rabbits. (1991) (74)
- Altered expression of proliferation and differentiation markers in human papillomavirus 16 and 18 immortalized epithelial cells grown in organotypic culture. (1992) (74)
- Does alveolar soft-part sarcoma exhibit skeletal muscle differentiation? An immunocytochemical and biochemical study of myogenic regulatory protein expression. (1996) (73)
- Practical Applications in Immunohistochemistry: Carcinomas of Unknown Primary Site. (2016) (73)
- Pharmacologically regulated in vivo selection in a large animal. (2002) (73)
- Cell proliferation in human soft tissue tumors correlates with platelet-derived growth factor B chain expression: an immunohistochemical and in situ hybridization study. (1994) (72)
- Best practices in diagnostic immunohistochemistry: myoepithelial markers in breast pathology. (2011) (71)
- Antibody HMB‐45 Identifies the Cells of Blue Nevi: An Immunohistochemical Study on Paraffin Sections (1990) (71)
- Isolation, characterization, and propagation in vitro of human glomerular endothelial cells (1984) (69)
- Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status. (2009) (69)
- Quality control in immunohistochemistry. Report of a workshop sponsored by the Biological Stain Commission. (1989) (69)
- Uterine carcinosarcoma: immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets. (2007) (68)
- Immunophenotype of ovarian cancer as predictor of clinical outcome: evaluation at primary surgery and second-look procedure. (1998) (68)
- CD34 EXPRESSION IN STROMAL TUMORS OF THE GASTROINTESTINAL-TRACT (1994) (67)
- The appearance, density and distribution of melanocytes in human embryonic and fetal skin revealed by the anti-melanoma monoclonal antibody, HMB-45 (2004) (66)
- Alterations in SPARC and VEGF immunoreactivity in epithelial ovarian cancer. (2000) (65)
- Immunohistochemical Markers of Melanocytic Tumors (2003) (64)
- Further investigations of the capacity of polynuclear aromatic hydrocarbons to elicit atherosclerotic lesions. (1981) (63)
- Utility of a Comprehensive Immunohistochemical Panel in the Differential Diagnosis of Spindle Cell Lesions of the Urinary Bladder (2009) (62)
- Diagnosis of rhabdomyosarcomas with HHF35, a monoclonal antibody directed against muscle actins. (1988) (62)
- Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer (2020) (60)
- The expression of epidermal growth factor receptor, HER-2/Neu, p53, and Ki-67 antigen in uterine malignant mixed mesodermal tumors and adenosarcoma. (1996) (60)
- Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series. (2001) (59)
- Detection of cell proliferation in tissue sections. (1993) (59)
- The fibroblast-like nature of myofibroblast (1988) (59)
- Unmasking the mysteries of antigen or epitope retrieval and formalin fixation. (2004) (59)
- GATA-3 Expression in Trophoblastic Tissues: An Immunohistochemical Study of 445 Cases, Including Diagnostic Utility (2015) (57)
- Diagnostic Immunohistochemistry: What Can Go Wrong and How to Prevent It. (2016) (56)
- Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count. (1999) (55)
- IMP3 and GLUT-1 Immunohistochemistry for Distinguishing Benign From Malignant Mesothelial Proliferations (2013) (54)
- Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration (2019) (54)
- Unique proteins defined by monoclonal antibodies specific for human melanoma. Some potential clinical applications. (1986) (54)
- Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group (2020) (54)
- False-positive immunostaining of normal epithelia and carcinomas with ascites fluid preparations of antimelanoma monoclonal antibody HMB45. (1991) (54)
- Cutaneous Chronic Graft-Versus-Host Disease Does Not Have the Abnormal Endothelial Phenotype or Vascular Rarefaction Characteristic of Systemic Sclerosis (2009) (53)
- p53 and mdm-2 expression in malignant melanoma: an immunocytochemical study of expression of p53, mdm-2, and markers of cell proliferation in primary versus metastatic tumors. (1995) (53)
- Fluorescence In Situ Hybridization for the Detection of t(X;18)(p11.2;q11.2) in a Synovial Sarcoma Tissue Microarray Using a Breakapart-Style Probe (2005) (52)
- Tenosynovial giant cell tumors: evidence for a desmin-positive dendritic cell subpopulation. (1998) (51)
- Molecular Phenotyping of Thyroid Tumors Identifies a Marker Panel for Differentiated Thyroid Cancer Diagnosis (2008) (51)
- Expression of the HPV16 E7 gene generates proliferation in stratified squamous cell cultures which is independent of endogenous p53 levels. (1992) (51)
- Markers of metastatic carcinoma of breast origin (2016) (50)
- A modified urokinase plasminogen activator induces liver regeneration without bleeding. (1995) (49)
- Quantitative Assessment of PD-L1 as an Analyte in Immunohistochemistry Diagnostic Assays using a Standardized Cell Line Tissue Microarray (2019) (47)
- Biomarker panel diagnosis of thyroid cancer: a critical review (2008) (47)
- Estrogen Receptor &agr; and Progesterone Receptor Expression in Ovarian Adult Granulosa Cell Tumors and Sertoli-Leydig Cell Tumors (2007) (47)
- Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma. (1995) (47)
- Heterogeneity of islet pathology in two infants with recent onset diabetes mellitus (2004) (46)
- Antibodies to desmin identify the blastemal component of nephroblastoma. (1997) (45)
- The mysteries of the myofibroblast (partially) unmasked. (1990) (45)
- Antibodies to Novel Myoepithelium-Associated Proteins Distinguish Benign Lesions and Carcinoma in Situ From Invasive Carcinoma of the Breast (1997) (44)
- Juvenile xanthogranuloma of the tongue. (1995) (43)
- Melanoma cell heterogeneity. A study of two monoclonal antibodies compared with s‐100 protein in paraffin sections (1988) (43)
- Activation of B lymphocyte maturation by a human follicular dendritic cell line, FDC-1. (1995) (43)
- Validation of the S-phase specificity of histone (H3) in situ hybridization in normal and malignant cells. (1996) (43)
- Distribution and pattern of expression of villin, a gastrointestinal-associated cytoskeletal protein, in human carcinomas: a study employing paraffin-embedded tissue. (1991) (42)
- Accuracy and precision in HER2/neu testing in breast cancer: are we there yet? (2004) (42)
- Instability of the myofibroblast phenotype in culture. (1990) (40)
- Personalized Oncogenomics: Clinical Experience with Malignant Peritoneal Mesothelioma Using Whole Genome Sequencing (2015) (39)
- Overexpression and relationships of HER-2/neu, epidermal growth factor receptor, p53, Ki-67, and tumor necrosis factor alpha in epithelial ovarian cancer. (1996) (39)
- The lung-restricted marker napsin A is highly expressed in clear cell carcinomas of the ovary. (2014) (38)
- PAX8 Expression in Uterine Adenocarcinomas and Mesonephric Proliferations (2014) (38)
- Metabolism of modified LDL by cultured human placental cells. (1995) (37)
- Comparative Sensitivities and Specificities of Antibodies to Breast Markers GCDFP-15, Mammaglobin A, and Different Clones of Antibodies to GATA-3: A Study of 338 Tumors Using Whole Sections (2016) (37)
- A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338. (2008) (36)
- Vaginal lymphatic channel location and its implication for intracavitary brachytherapy radiation treatment. (2005) (35)
- Evaluation of chemoresistance markers in women with epithelial ovarian carcinoma. (2001) (34)
- p16 FISH Deletion in Surface Epithelial Mesothelial Proliferations Is Predictive of Underlying Invasive Mesothelioma (2014) (34)
- Implementation of a Canadian External Quality Assurance Program for Breast Cancer Biomarkers: An Initiative of Canadian Quality Control in Immunohistochemistry (cIQc) and Canadian Association of Pathologists (CAP) National Standards Committee/Immunohistochemistry (2009) (33)
- Immunophenotype of vascular rejection in renal transplants. (1990) (33)
- Muscle-specific protein expression in normal salivary glands and pleomorphic adenomas: an immunocytochemical study with biochemical confirmation. (1991) (33)
- Coordinated expression of galectin‐3 and caveolin‐1 in thyroid cancer (2012) (30)
- Investigation of PD-L1 Biomarker Testing Methods for PD-1 Axis Inhibition in Non-squamous Non–small Cell Lung Cancer (2016) (30)
- Immunohistochemistry as an adjunct in the differential diagnosis of radiation-induced atypia versus urothelial carcinoma in situ of the bladder: a study of 45 cases. (2013) (30)
- Immunohistochemistry for TFE3 lacks specificity and sensitivity in the diagnosis of TFE3-rearranged neoplasms: a comparative, 2-laboratory study. (2019) (29)
- Apoptosis of vascular smooth muscle cells is induced by Fas ligand derived from monocytes/macrophage. (2003) (29)
- Relationship Between Clinical and Pathologic Features of Ductal Carcinoma In Situ and Patient Age: An Analysis of 657 Patients (2009) (29)
- Bone marrow involvement in epithelial ovarian cancer by immunocytochemical assessment. (1990) (28)
- Monoclonal Antibodies to Intermediate Filament Proteins (1984) (28)
- Pulmonary Hyalinizing Granuloma With Associated Elevation in Serum and Tissue IgG4 Occurring in a Patient With a History of Sarcoidosis (2012) (28)
- The fibroblast-like nature of myofibroblasts. (1988) (27)
- Evaluation of type 1 growth factor receptor family expression in benign and malignant thyroid lesions. (2008) (26)
- Oncogene Expression: Long‐Term Compared With Short‐Term Survival in Patients With Advanced Epithelial Ovarian Cancer (1998) (26)
- Characterization of an embryonal rhabdomyosarcoma cell line showing amplification and over‐expression of the N‐myc oncogene (1990) (24)
- A Multi-Institutional Study to Evaluate Automated Whole Slide Scoring of Immunohistochemistry for Assessment of Programmed Death-Ligand 1 (PD-L1) Expression in Non–Small Cell Lung Cancer (2019) (24)
- Primary Versus Metastatic Pulmonary Adenocarcinoma: An Immunohistochemical Study Using Villin and Cytokeratins 7 and 20 (1996) (24)
- Immunohistochemical distribution of lipoprotein epitopes in xanthomata from patients with familial hypercholesterolemia. (1992) (24)
- Human arterial smooth muscle cells in culture: Inverse relationship between proliferation and expression of contractile proteins (1989) (24)
- Evaluation of contemporary prostate and urothelial lineage biomarkers in a consecutive cohort of poorly differentiated bladder neck carcinomas. (2014) (24)
- Correspondence Re: Varma M, Linden MD, Amin MB. Effect of Formalin Fixation and Epitope Retrieval Techniques on antibody 34βE12 Immunostaining of Prostatic Tissues. Mod Pathol 1999;12:472–8 (2000) (23)
- AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus. (1996) (23)
- Multicellular origin of parathyroid "adenomas". (1978) (23)
- Genogenic immunohistochemistry: a new era in diagnostic immunohistochemistry (2002) (23)
- Atheroma: the artery wall and the environment. (1980) (23)
- Correlative light and electron microscopic immunocytochemistry on the same section with colloidal gold. (1987) (23)
- Identification of subpopulations of mouse thymic epithelial cells in culture. (1989) (22)
- Metastatic renal cell carcinoma. (1985) (21)
- Mesothelial pelvic lymph node inclusions mimicking metastatic thyroid carcinoma. (1998) (21)
- Clinical utility of type 1 growth factor receptor expression in colon cancer. (2008) (21)
- Is classic Kaposi's sarcoma endemic in Peru?: report of a case in an indigenous patient. (2006) (18)
- Mixed carcinoid and adenocarcinoma of the appendix: report of 4 cases with immunohistochemical studies and a review of the literature. (2004) (18)
- Paget's disease and melanoma of the vulva. Use of a panel of monoclonal antibodies to identify cell type and to microscopically define adequacy of surgical margins. (1992) (18)
- Reply to “…and secreted tumour suppressors” (1996) (18)
- Carcinosarcoma of the floor of mouth. (1985) (17)
- Expression of c-erb B-2 oncogene product in persistent gestational trophoblastic disease. (1994) (17)
- Abnormalities of p53 and p110RB tumor suppressor gene expression in human soft tissue tumors: correlations with cell proliferation and tumor grade. (1995) (16)
- Avidin-biotin-immunoglucose oxidase: use in single and double labeling procedures. (1986) (16)
- Immunolocalization of estrogen and progesterone receptors in neuroendocrine tumors of lung, skin, gastrointestinal and female genital tracts (1997) (16)
- Immunophenotyping of thyroid tumors identifies molecular markers altered during transformation of differentiated into anaplastic carcinoma. (2011) (16)
- Antineuroblastoma antibody NB-84 also identifies a significant subset of other small blue round cell tumors (1997) (15)
- PAX8 Expression in Uterine Malignant Mesodermal Mixed Tumor (Carcinosarcoma) (2014) (15)
- Immunohistochemical Characterization of Squamous Differentiation and Morular Metaplasia in Uterine Endometrioid Adenocarcinoma (2012) (15)
- Role of SATB2 in distinguishing the site of origin in glandular lesions of the bladder/urinary tract. (2017) (14)
- Persistent hepatitis C virus infection after liver transplantation (1995) (14)
- Cell type and cell state specific antibodies in the analysis of early lesions of human atherosclerosis. (1992) (13)
- Abnormal Expression of the Cystic Fibrosis Transmembrane Regulator in Chronic Sinusitis in Cystic Fibrosis and Non-Cystic Fibrosis Patients (1999) (13)
- Lactate dehydrogenase (LDH) isozymes of human atherosclerotic plaques. (1982) (13)
- SATB2 protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours (2020) (13)
- Human papillomavirus-immortalized keratinocytes are resistant to the effects of retinoic acid on terminal differentiation. (1993) (12)
- HER2 in well differentiated breast cancer: is testing necessary? (2008) (12)
- Methotrexate compared with mercaptopurine for early induced abortion. (1999) (12)
- Predictive utility of cyclo-oxygenase-2 expression by colon and rectal cancer. (2014) (11)
- Microvascular endothelium of human tumor xenografts expresses mouse (= host) CD31. (1997) (11)
- Analysis of proliferative grade in glial neoplasms using antibodies to the Ki-67 defined antigen and PCNA in formalin fixed, deparaffinized tissues (2005) (10)
- Testing for epidermal growth factor receptor in lung cancer: have we learned anything from HER-2 testing? (2004) (10)
- Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials (2020) (10)
- The utility of immunocytochemistry in invasive adenocarcinoma of the cervix. (1992) (10)
- Antibodies to Cytokeratin 14 Specifically Identify Oncocytes (H??rthle Cells) in Thyroid Lesions and Tumors (1997) (10)
- Hamster thecal cells express muscle characteristics. (1988) (10)
- Macrophage origin of the multinucleated cells of myeloma cast nephropathy. (1989) (9)
- IMMUNOHISTOCHEMICAL DETERMINATION OF PRIMARY SITES OF CARCINOMAS (1999) (9)
- Monoclonal antibodies to intermediate filament proteins. Use in diagnostic surgical pathology. (1984) (9)
- Review of selected lineage-directed antibodies useful in routinely processed tissues. (1989) (8)
- Intermediate filaments in the developing type II cell of fetal monkey lung. (1985) (8)
- Expression of Her-2/neu oncogene protein product and epidermal growth factor receptors in surgical specimens of human breast cancers. (1991) (8)
- Specificity of antibody HMB-45. (1992) (7)
- Anti-intermediate filament monoclonal antibodies: tissue-specific tools in tumor diagnosis. (1984) (7)
- Tweaking and nudging toward improved-IHC quality. (2009) (6)
- Localization of proteoheparan sulfate in rat aorta (2004) (6)
- The knowns and the unknowns in HER2 testing in breast cancer. (2011) (6)
- Do we need two more mesothelial markers? (2005) (6)
- Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials (2020) (6)
- DO GLIOMA-CELLS EXPRESS CYTOKERATIN (1995) (6)
- A 90-kDa surface antigen of immature smooth muscle cells is ICAM-1. (1991) (5)
- Leong's Manual of Diagnostic Antibodies for Immunohistology (2016) (5)
- Monoclonal antibodies to intermediate filament proteins: diagnostic specificity in orbital pathology. (1988) (5)
- Salivary Gland Basal Cell and Canalicular Adenomas (2009) (5)
- Paget's disease and melanoma of the vulva. Use of a panel of monoclonal antibodies to identify cell type and to microscopically define adequacy of surgical margins (1993) (5)
- AIDS-associated B-cell non-Hodgkin's lymphoma masquerading as a cutaneous T-cell neoplasm: an aberrant immunophenotype requiring comprehensive analysis for lineage resolution. (1997) (5)
- Immunohistochemical Analysis of Carcinomas of Unknown Primary Site (1999) (5)
- "Professional" and "nonprofessional" contractile cells in the lung. (1990) (4)
- Controversies and guidelines in tissue-based HER-2/neu testing in breast cancer. (2002) (4)
- Detection of pelvic node metastases. (2000) (4)
- PTEN (phosphatase and tensin homolog deleted on chromosome 10) (2016) (4)
- Oncogene Expression: Long-Term Compared With Short-Term Survival in Patients With Advanced Epithelial Ovarian Cancer (1998) (4)
- HHF35, A Muscle-A ctin-Specific Monoclonal Antibody I. Immunocytochemical and Biochemical Characterization (2007) (4)
- Bone marrow involvement in epithelial ovarian cancer by immunocytochemical assessment (1991) (4)
- Induction of Acidic Fibroblast Growth Factor and Full-Length Platelet-Derived Growth Factor Expression in Human Cardiac Allografts : Analysis by PCR , In Situ Hybridization , and Immunohistochemistry (2005) (4)
- USES OF ANTIBODY PANELS IN THE ANALYSIS OF METASTATIC CARCINOMAS OF UNKNOWN PRIMARY (1999) (4)
- Evaluation of Human Epidermal Growth Factor Receptor 2 (HER2) Gene Status in Human Breast Cancer Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Specimens by Fluorescence In Situ Hybridization (FISH). (2016) (3)
- Definitive diagnosis of pleural mesothelioma can be established on a small panel of immunohistochemical markers using logic regression, a novel statistical method (2003) (3)
- The urokinase plasminogen activator receptor (uPAR) is a chokepoint for carcinoma metastasis and angiogenesis (2000) (3)
- An EBV-Associated Salivary Gland Cancer (1985) (3)
- Fixation time does not affect expression of HER2/neu. (2011) (3)
- On the use of cytokeratins 7 and 20 in the differentiation between transitional cell carcinoma and prostate adenocarcinoma. (2001) (3)
- Keratins versus epithelial membrane antigen. (1988) (3)
- IMMUNOCYTOCHEMICAL DIFFERENTIATION OF REACTIVE HYPERPLASIA FROM FOLLICULAR LYMPHOMA USING MONOCLONAL-ANTIBODIES TO CELL-SURFACE AND PROLIFERATION-RELATED MARKERS (1994) (3)
- Detection of infectious disease agents in tissue by immunocytochemistry. (1994) (3)
- Expression of the HPV 16 E 7 Gene Generates Proliferation in Stratified Squamous Cell Cultures Which Is Independent of Endogenous p 53 Levels ’ (2005) (3)
- CD34 IS A SENSITIVE MARKER OF GASTROINTESTINAL STROMAL CELL TUMORS (1993) (3)
- Modern Immunohistochemistry in Targeted Therapy (2013) (3)
- Molecular vs . Immunohistochemical Classification of Breast Cancer (3)
- Type III hyperlipoproteinemia and atherosclerosis: a case report and re-evaluation. (1982) (3)
- Vascular endothelial growth factor expression and survival in node positive breast cancer patients treated with adjuvant therapy. (2004) (3)
- Diagnostic Approach to Hepatic Mass Lesions and Role of Immunohistochemistry. (2013) (3)
- Abstract P5-02-01: Analytical validation and prognostic potential of an automated digital scoring protocol for Ki67: An International Ki67 Working Group study (2020) (3)
- Multivariate analysis of expression of the microtubule-associated protein, tau, predicts improved progression free and overall survival in patients with metastatic HER-2-negative breast cancers treated with docetaxel and vinorelbine plus filgrastim. (2006) (3)
- Immunocytochemical Analysis of the Cellular Composition of Atherosclerotic Lesions in the Human Aorta (1990) (2)
- Human A theroscierosis II. Immunocytochemical Analysis of the Cellular Composition of Human Atherosclerotic Lesions (2007) (2)
- Cultured circular smooth muscle from the rabbit colon (1986) (2)
- Pcna cyclin expression and brdu uptake define different subpopulations of cells in different cell lines (1989) (2)
- Synovitis After Anterior Cruciate Ligament Reconstruction Effusion: Confusion (1988) (2)
- Concordance between human epidermal growth factor receptor 2 testing by reverse transcriptase polymerase chain reaction and fluorescent in situ hybridization. (2012) (2)
- Discrepancies between immunohistochemistry and fluorescence in situ hybridization for HER-2 testing in breast cancer: The role of a quality assurance program on a cohort of 3564 patients. (2004) (2)
- CDX2 (caudal type homeobox 2) (2016) (2)
- Vascular mesangial channels in human nodular diabetic glomerulopathy. (2016) (2)
- Differential diagnosis of genitourinary tumors using monoclonal antibodies to intermediate filament proteins. (1989) (2)
- Pathology of Human Neoplasms: An Atlas of Diagnostic Electron Microscopy and Immunohisto-chemistry (1989) (2)
- New applications of monoclonal antibodies to the diagnosis and prognosis of breast cancer. (1990) (2)
- A Pilot Validation Study Comparing FIBI, a Slide-Free Imaging Method, with Standard FFPE H&E Tissue Section Histology for Primary Surgical Pathology Diagnosis (2022) (2)
- Sensitivity of immunohistochemical detection of EGFR could impact patient eligibility for anti-EGFR therapy (2005) (2)
- From 3H to H3: Slide-Based Analyses of the Cell Cycle (1995) (2)
- Merkel cell carcinoma (2000) (2)
- Anaplastic thyroid carcinoma exhibits intratumoral molecular homogeneity for a therapeutic target panel. (2009) (1)
- P4-09-04: Do Decreased CEP17 Signals Indicate the Presence of “Monosomy” in Breast Cancer? A Study of HER2 Gene Status and HER2 Immunohistochemistry. (2011) (1)
- Signal transducer and activator of transcription–3 (STAT3) expression concordance in paired primary and metastatic colorectal cancers (mCRC) (2016) (1)
- The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group (2021) (1)
- Personalized medicine-molecular targeted cancer therapy (2009) (1)
- Next Generation Immunohistochemistry ( IHC ) : A Window Onto the Molecular Biology of Tumors (2013) (1)
- Ulex europaeus agglutinin 1 lectin (UEA-1) (2016) (1)
- Anaplastic lymphoma kinase (ALK) (2016) (1)
- Amplification involving the CEP17 region may lead to false negative results of HER2 gene amplification by FISH. (2009) (1)
- OLIG2 (oligodendrocyte transcription factor 2) (2016) (1)
- Phosphorylated transducer and activator of transcription-3 (pSTAT3) immunohistochemical expression in paired primary and metastatic colorectal cancer (2020) (1)
- Is albumin mRNA detection in the diagnosis of hepatocellular carcinoma better than existing markers? (2000) (1)
- Mono clonal antibody to smooth muscle actins (1984) (1)
- MSA (muscle-specific actin) (2016) (1)
- Melanoma specific monoclonal antibodies recognize a cytoplasmic antigen (1984) (1)
- Pax8 Expression in Uterine Malignant Mesodermal Mixed Tumor (Carcinosarcoma): Immunohistochemical Analysis of 37 Cases (2012) (1)
- HMB-45 (melanoma marker) (2016) (1)
- Canadian external quality assurance program for breast cancer biomarkers. (2010) (1)
- False positive immunostaining of myofibroblasts and pericytes with antibodies to SMM-HC and calponin A pitfall in the interpretation of myoepithelial markers in breast lesions (2001) (1)
- PSAP (prostate-specific acid phosphatase) (2016) (1)
- CD56 (neural cell adhesion molecule) (2016) (1)
- Antibodies to CD10 can positively identify endometriotic stroma in pelvic biopsy specimens equivocal by histologic examination (2001) (0)
- The Use of Immunohistochemistry for Analysis of the Lesions of Atherosclerosis. (1990) (0)
- Human papillomavirus (HPV) (2016) (0)
- PSA (prostate-specific antigen) (2016) (0)
- EMA (epithelial membrane antigen) (2016) (0)
- Mono clonal antibodies to intermediate filament proteins of human cells (1981) (0)
- CD54 (ICAM-1) (2016) (0)
- Human immunodeficiency virus (HIV) (2016) (0)
- Immunocytochemical identification of vulvar melanoma and distinction from Paget's cells with monoclonal antibodies (1986) (0)
- Immunohistochemistry of Small Blue Round Cell Tumors (2002) (0)
- DBA.44 (hairy cell leukemia) (2016) (0)
- Role of pathologists in the molecular targeted therapy of cancer (2004) (0)
- Fascin expression is not restricted to Hodgkin's disease and does not correlate with presence of EBV. (1997) (0)
- Cytokeratin 20 (CK20) (2016) (0)
- Factor VIII RA (vonWillebrand factor) (2016) (0)
- Forkhead box L2 (FOXL2) (2016) (0)
- T-cell receptor (2016) (0)
- TNF-A and il-6 production in the chorioamnion at term by macrophages of maternal and fetal origin as determined in vivo by mrna in situ hybridization and immunohistology troos (1996) (0)
- Expression of potential therapeutic targets COX-2 and c-kit in breast cancer: Assessment and correlations using tissue microarrays (2003) (0)
- Mutated IDH-1 (mIDH1-R132H, R132S, R132G) (2016) (0)
- Immunohistochemistry: The Complexity of the Simple (1999) (0)
- Collagen type IV (2016) (0)
- Cytokeratins: MAK-6 (2016) (0)
- Pancreatic hormones: insulin, somatostatin, vasoactive intestinal polypeptide, gastrin, glucagon, pancreatic polypeptide (2016) (0)
- Smooth muscle myosin heavy chain (2016) (0)
- Expression of c-erb B-2 oncogene gestational trophoblastic disease product in persistent (1994) (0)
- SF-007-1 Improving preoperative diagnosis of thyroid cancer : a molecular perspective (2008) (0)
- CD74 (LN-2) (2016) (0)
- The 2000 Long Course. Conclusion. (2001) (0)
- Other pan-cytokeratin cocktails (2016) (0)
- 115. Effect Fixation on Immunocytochemical Localization of Immunoglobulins in Human Tonsils. (1982) (0)
- Abstract 1695: A multi-institutional study to evaluate automated scoring of immunohistochemistry slides for assessment of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer (2018) (0)
- Hepatic Veno-occiusive Disease After Bone Marrow Transplantation (2007) (0)
- Earl Philip Benditt 1916–1996 (1997) (0)
- Pregnancy-specific -1-glycoprotein (SP1) (2016) (0)
- Editorial Comments (1956) (0)
- Simian virus 40 (SV40 T antigen) (2016) (0)
- CD45 (leukocyte common antigen) (2016) (0)
- Gross cystic disease fluid protein 15 (GCDFP-15, BRST-2) (2016) (0)
- Herpes simplex virus I and II (HSV I and II) (2016) (0)
- Cytokeratin 5/6 (CK5/6) (2016) (0)
- Evans' Histological Appearances of Tumours, Ed. 3, David J.B. Ashley. Churchill Livingstone, Edinburgh (1978), (Distributed in the United States by Longman, Inc., New York, New York.) Two volumes, 857 illustrations, 1457 pages. $85.60 the set. (1981) (0)
- Leong's Manual of Diagnostic Antibodies for Immunohistology: VEGF (vascular endothelial growth factor) (2016) (0)
- CD30 (Ki-1) (2016) (0)
- Terminal deoxynucleotidyl transferase (TdT) (2016) (0)
- Human placental lactogen (hPL) (2016) (0)
- SDHB (succinate dehydrogenase complex, subunit B) (2016) (0)
- Mutated BRAF V600E (2016) (0)
- 232 Current status of immunohistochemical studies for the diagnosis of mesothelioma (2006) (0)
- P1-11 Multispectral imaging for multicolor immunohistochemical and transmission in-situ hybridization (2002) (0)
- Hep Par 1 (hepatocyte marker) (2016) (0)
- C-kit (CD117) is a uniform marker of non-neoplastic breast tissue and is also expressed in a unique subset of breast cancers (1999) (0)
- GATA binding protein 3 (GATA3) (2016) (0)
- The pathologists and team at PhenoPath (2016) (0)
- Microphthalmia transcription factor (MiTF) (2016) (0)
- Appendix 1 Selected antibody panels for specific diagnostic situations (2016) (0)
- Human parvovirus B19 (2016) (0)
- The 2000 Long Course. Introduction. (2001) (0)
- Hepatitis B surface antigen (HBsAg) (2016) (0)
- Genogenicimmunohistochemistry:a newera indiagnosticimmunohistochemistry (2002) (0)
- N/97-Cadherin/E-Cadherin (2016) (0)
- PLAP (placental alkaline phosphatase) (2016) (0)
- Immunohistochemical analysis of p110RB expression in human cells and tissues (1996) (0)
- Fas (CD95) and Fas-ligand (CD95L) (2016) (0)
- Cytokeratins: CAM 5.2 (2016) (0)
- Regulated Mechanism − β by a Transforming Growth Factor-In vivo Progression Inhibits Tumor 6 β v α Antibody-Mediated Blockade of Integrin (2008) (0)
- The Biomarker Ki-67: Promise, Potential, and Problems in Breast Cancer. (2022) (0)
- P-glycoprotein (P-170), multidrug resistance (MDR) (2016) (0)
- Anaplastic Thyroid Carcinoma Exhibits Intratumoral Molecular Homogeneity (2009) (0)
- Commentary on “Application of Photoshop-based Image Analysis to Quantification of Hormone Receptor Expression in Breast Cancer” (2022) (0)
- Retinoblastoma gene protein (P110RB, Rb protein) (2016) (0)
- Appendix 3 Antibody applications (2016) (0)
- Phosphohistone H3 (pHH3) (2016) (0)
- hCG (human chorionic gonadotropin) (2016) (0)
- Myogenin is a highly specific and sensitive marker for tumors with rhahdomyogenic differentiation (1996) (0)
- Antibodies to caspase 3 fragment, a novel marker of apoptotic cells, can distinguish follicular lymphoma from reactive follicular hyperplasia (2001) (0)
- Correspondence re: Shah IA, Schlageter M-O, Stinnet P, Lechago J: Cytokeratin immunohistochemistry as a diagnostic tool for distinguishing malignant from benign epithelial lesions of the prostate. Mod Pathol 4:220, 1991. (1992) (0)
- A comprehensive study of immunohistochemical markers in the distinction between pleural mesothelioma and adenocarcinoma: Emphasis on sensitivity and specificity of newly defined markers (2002) (0)
- Monoclonal Antibody Directed Against (2007) (0)
- -Smooth muscle actin (-SMA) (2016) (0)
- Epstein–Barr virus, LMP (2016) (0)
- MDM-2 protein (2016) (0)
- Immunoglobulins: Igκ, Igλ, IgA, IgD, IgE, IgG, IgM (2016) (0)
- Surfactant apoprotein A (2016) (0)
- IMMUNOLOCALIZATION OF ESTROGEN AND PROGESTERONE RECEPTORS IN THE SPECTRUM OF NEUROENDOCRINE CARCINOMAS OF LUNG, GI TRACT, SKIN, OVARY AND CERVIX (1995) (0)
- CYTOKERATIN (CK)-7 AND CK-20 IMMUNOPHENOTYPING CAN DISTINGUISH AMONG CARCINOMAS OF DIFFERENT PRIMARY SITES - AN IMMUNOHISTOCHEMICAL STUDY (1995) (0)
- EXPRESSION OF MYOGENIC REGULATORY PROTEINS (MYOGENIN AND MYOD1) AND MUSCLE-SPECIFIC CYTOSKELETAL PROTEINS IN ALVEOLAR SOFT PART SARCOMA (1995) (0)
- Reply to Hanna et al. (2008) (0)
- Glial fibrillary acidic protein (GFAP) (2016) (0)
- Epidermal growth factors: EGFR (2016) (0)
- Mono clonal antibodies to glucose 6 phosphate dehydrogenase and intermediate filaments in the study of the origins of human neoplasia (1981) (0)
- Determining true HER2 status in breast cancers with polysomy using alternative chromosome 17 reference genes: Implications for trastuzumab therapy. (2010) (0)
- Cytokeratin 19 (CK19) (2016) (0)
- Isolating trophoblasts from maternal peripheral blood for prenatal genetic screening (1994) (0)
- Book Review (2001) (0)
- hMLH1 and hMSH2 (mismatch repair proteins) (2016) (0)
- Parathyroid hormone-related protein (PTHrP) (2016) (0)
- K-ras mutation, P-53 and C-ERBB-2 over-expression in the neoplastic progression of intraductal papillary-mucinous tumors of the pancreas (1998) (0)
- Abstract P2-03-01: Analytical validation of a standardized scoring protocol for Ki67 assessed on breast excision whole sections: An international multicenter collaboration (2018) (0)
- Progesterone receptor (PR) (2016) (0)
- Cytotoxic molecules (TIA-1, granzyme B, perforin) (2016) (0)
- Appendix 2 Antibody panels for lymphoid neoplasms (2016) (0)
- Phosphorylated signal transducer and activator of transcription–3 (p-STAT3) expression concordance in paired primary and metastatic colorectal cancers (mCRC): Updated analysis. (2017) (0)
- Pituitary hormones: ACTH, FSH, hGH, LH, PRL, TSH (2016) (0)
- Abstract P1-07-01: Attainment of extremely high concordance rates between fluorescence in situ hybridization and immunohistochemistry in testing for human epidermal growth factor receptor 2 (HER2) in breast cancer using a normalized scoring system for immunohistochemistry: a four year experience wit (2012) (0)
- Ki-67 (MIB1, Ki-S5) (2016) (0)
- c-erbB-2 (HER2, neu) (2016) (0)
- Commentary on Lehr, Hans-Anton, et al. (1997). (2022) (0)
- Cytokeratin 7 (CK7) (2016) (0)
- Immunocytochemistry in patients with ovarian granulosa cell tumors (1996) (0)
- Proto-oncogene tyrosine-protein kinase 1 (ROS1) (2016) (0)
- Protein gene product 9 9.5 (PGP.5) (2016) (0)
- S6-2 Correlation of FISH and IHC in low level alterations of HER-2/neu (2002) (0)
- Cytokeratins: AE1/AE3 (2016) (0)
- PAX-2 (paired box gene 2) (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Allen M. Gown?
Allen M. Gown is affiliated with the following schools:
